Παρακαλώ χρησιμοποιήστε αυτό το αναγνωριστικό για να παραπέμψετε ή να δημιουργήσετε σύνδεσμο προς αυτό το τεκμήριο: https://hdl.handle.net/10442/18515
Export to:   BibTeX  | EndNote  | RIS
Εξειδίκευση τύπου : Άρθρο σε επιστημονικό περιοδικό
Τίτλος: The Impact of the Oil Phase Selection on Physicochemical Properties, Long-Term Stability, In Vitro Performance and Injectability of Curcumin-Loaded PEGylated Nanoemulsions
Δημιουργός/Συγγραφέας: Đoković, Jelena B
Demisli, Sotiria
Savić, Sanela M
Marković, Bojan D
Cekić, Nebojša D
Randjelovic, Danijela V
Mitrović, Jelena R
Lunter, Dominique Jasmin
[EL] Παπαδημητρίου, Βασιλική[EN] Papadimitriou, Vassilikisemantics logo
[EL] Ξενάκης, Αριστοτέλης[EN] Xenakis, Aristotelissemantics logo
Savić, Snežana D
Ημερομηνία: 2022-08-10
Γλώσσα: Αγγλικά
ISSN: 1999-4923
DOI: 10.3390/pharmaceutics14081666
Άλλο: 36015291
Περίληψη: A nanotechnology-based approach to drug delivery presents one of the biggest trends in biomedical science that can provide increased active concentration, bioavailability, and safety compared to conventional drug-delivery systems. Nanoemulsions stand out amongst other nanocarriers for being biodegradable, biocompatible, and relatively easy to manufacture. For improved drug-delivery properties, longer circulation for the nanoemulsion droplets should be provided, to allow the active to reach the target site. One of the strategies used for this purpose is PEGylation. The aim of this research was assessing the impact of the oil phase selection, soybean or fish oil mixtures with medium chain triglycerides, on the physicochemical characteristics and injectability of curcumin-loaded PEGylated nanoemulsions. Electron paramagnetic resonance spectroscopy demonstrated the structural impact of the oil phase on the stabilizing layer of nanoemulsions, with a more pronounced stabilizing effect of curcumin observed in the fish oil nanoemulsion compared to the soybean oil one. The design of the experiment study, employed to simultaneously assess the impact of the oil phase, different PEGylated phospholipids and their concentrations, as well as the presence of curcumin, showed that not only the investigated factors alone, but also their interactions, had a significant influence on the critical quality attributes of the PEGylated nanoemulsions. Detailed physicochemical characterization of the NEs found all formulations were appropriate for parenteral administration and remained stable during two years of storage, with the preserved antioxidant activity demonstrated by DPPH and FRAP assays. In vitro release studies showed a more pronounced release of curcumin from the fish oil NEs compared to that from the soybean oil ones. The innovative in vitro injectability assessment, designed to mimic intravenous application, proved that all formulations tested in selected experimental setting could be employed in prospective in vivo studies. Overall, the current study shows the importance of oil phase selection when formulating PEGylated nanoemulsions.
Τίτλος πηγής δημοσίευσης: Pharmaceutics
Τόμος/Κεφάλαιο: 14
Τεύχος: 8
Θεματική Κατηγορία: [EL] Νανοτεχνολογία[EN] Nanotechnologysemantics logo
[EL] Φασματοσκοπία[EN] Spectroscopysemantics logo
[EL] Χημική Βιολογία[EN] Chemical Biologysemantics logo
[EL] Βιοτεχνολογία[EN] Biotechnologysemantics logo
Λέξεις-Κλειδιά: D-optimal experimental design
PEGylated nanoemulsions
Curcumin
Electron paramagnetic resonance spectroscopy
Fish oil
Injectability
EU Grant identifier: 7749108
451-03-68/2022-14/200161
451-03-68/2022-14/200026
Κάτοχος πνευματικών δικαιωμάτων: © 2022 by the authors
Όροι και προϋποθέσεις δικαιωμάτων: This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https:// creativecommons.org/licenses/by/ 4.0/).
Ηλεκτρονική διεύθυνση στον εκδότη (link): https://www.mdpi.com/1999-4923/14/8/1666
Εμφανίζεται στις συλλογές:Ινστιτούτο Χημικής Βιολογίας - Επιστημονικό έργο

Αρχεία σε αυτό το τεκμήριο:
Αρχείο Περιγραφή ΣελίδεςΜέγεθοςΜορφότυποςΈκδοσηΆδεια
Dokovic et al_2022_pharmaceutics-14-01666-v3.pdfopen access article5.82 MBAdobe PDFΔημοσιευμένη/του ΕκδότηccbyThumbnail
Δείτε/ανοίξτε
pharmaceutics-1815554-supplementary.pdfsupplementary material1.44 MBAdobe PDF-ccbyThumbnail
Δείτε/ανοίξτε